Nuvation Bio Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
2.17 |
13.79 |
81.17 |
129.97 |
310.59 |
627.58 |
| Przychód Δ r/r |
0.00% |
535.49% |
488.73% |
60.11% |
138.97% |
102.06% |
| Przychód (min) |
2.16 |
13.61 |
22.43 |
125.33 |
115.07 |
232.52 |
| Przychód (max) |
2.20 |
13.95 |
144.96 |
134.61 |
520.62 |
1,051.96 |
| EBITDA (średnia) |
1.30 |
8.27 |
48.70 |
77.98 |
186.35 |
376.55 |
| EBIT (średnia) |
1.30 |
8.27 |
48.70 |
77.98 |
186.35 |
376.55 |
| EBIT % |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
| Zysk netto (średni) |
-580.45 |
-174.70 |
-195.53 |
-139.50 |
-55.77 |
366.42 |
| Zysk netto % |
-26753.69% |
-1267.09% |
-240.88% |
-107.34% |
-17.96% |
58.39% |
| EPS (średnia) |
-2.12 |
-0.65 |
-0.59 |
-0.51 |
-0.21 |
1.36 |
| Liczba analityków (Przychody) |
4 |
4 |
7 |
4 |
2 |
3 |
| Liczba analityków (EPS) |
3 |
2 |
4 |
3 |
1 |
1 |
| symbol |
NUVB |
NUVB |
NUVB |
NUVB |
NUVB |
NUVB |